Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
Compass Pathways Elects Kathleen Tregoning to Board of Directors
06:30am, Thursday, 28'th May 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways: A Trip Worth Taking Before The FDA Verdict
08:39am, Wednesday, 27'th May 2026
COMPASS Pathways (CMPS) is positioned to pioneer COMP360, the first psychedelic drug for treatment-resistant depression (TRD), with expected FDA approval later this year. COMP360 demonstrated primary
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
02:03am, Thursday, 21'st May 2026
Compass Pathways NASDAQ: CMPS executives said the company remains on track to target a fourth-quarter New Drug Application filing for COMP360, its synthetic psilocybin treatment candidate for treatmen
Compass Pathways: Imminent Commercialization Should Provide Further Upside
08:36pm, Thursday, 14'th May 2026
Compass Pathways is nearing an inflection point, with solid Phase III data and government support pointing towards a likely FDA approval. CMPS is positioned to address the large, underserved treatment
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
07:00am, Thursday, 14'th May 2026
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
06:30am, Thursday, 14'th May 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript
04:00pm, Wednesday, 13'th May 2026
COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript
Compass Pathways shares rise on Q1 results, accelerated FDA review
12:34pm, Wednesday, 13'th May 2026
Compass Pathways (NASDAQ:CMPS) shares rose 14% after it reported first quarter results that topped expectations and showed continued regulatory progress for its lead therapy COMP360 in treatment-resis
Compass Pathways Q1 Earnings Call Highlights
10:08am, Wednesday, 13'th May 2026
Compass Pathways NASDAQ: CMPS said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for
Compass Pathways shares rise on Q1 results, accelerated FDA review
08:33am, Wednesday, 13'th May 2026
Compass Pathways (NASDAQ:CMPS) shares rose 14% after it reported first quarter results that topped expectations and showed continued regulatory progress for...
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights
07:00am, Wednesday, 13'th May 2026
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today repo
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights
06:30am, Wednesday, 13'th May 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026
06:30am, Wednesday, 06'th May 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:25am, Wednesday, 06'th May 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Pre-Market Stock Futures: Futures are trading lower as we start off the new week, as oil surges higher amid reports that a U.S. warship was turned back in the Strait of Hormuz, but what a start we had
